PORTFOLIO

Early-Stage Advantage

Via our prior early-stage funds and as individual angels and strategic investors, the Neovate team has invested more than $150 million, enabling dozens of tech and life sciences startups to reach key milestones, from clinical validation and commercial launch to strategic partnership and exit. Some of the representative investments are listed below.

Investments made by Mountain State Capital led by Matt Harbaugh, Mike Green, Nick Pachuda

Investments made by Kevin Rocco (Angel)

Investments made by Johnson & Johnson led by Nick Pachuda

Card image

Avisi

Nanotechnology-enabled glaucoma device

Kevin Rocco IconKevin Rocco
Mountain State Icon Mountain State Capital
Year Icon2022
Card image

Biorez

Collagen-based implant improving tendon/ligament repair

Kevin Rocco IconKevin Rocco
Year Icon2020
Star IconExited
Card image

Caira

Surgical navigation system

Mountain State Icon Mountain State Capital
Year Icon2021
Card image

Discgenics

Degenerative disc disease cell therapy

Johnson & Johnson Icon Johnson & Johnson
Year Icon2016
Card image

Discure

Degenerative disc disease device

Johnson & Johnson Icon Johnson & Johnson
Year Icon2016
Card image

Nanochon

Cartilage repair & regeneration system

Mountain State Icon Mountain State Capital
Year Icon2021
Card image

Ocugenix

Opthalmic drug for wet AMD and geographic atrophy

Mountain State Icon Mountain State Capital
Year Icon2022
Card image

Orthotaxy

Orthopedic Robotics

Johnson & Johnson Icon Johnson & Johnson
Year Icon2018
Star IconAcquired
Card image

Osteal

Antinfection drug/device combination

Johnson & Johnson Icon Johnson & Johnson
Year Icon2017
Card image

PECA Labs

Synthetic heart valves & vascular grafts

Mountain State Icon Mountain State Capital
Year Icon2019
Card image

Peptilogics

Anti-infective drug for prosthetic joint infections

Mountain State Icon Mountain State Capital
Year Icon2023
Card image

Phoenix Kinetics

World's first synthetic misnicus replacement

Kevin Rocco IconKevin Rocco
Year Icon2023
Team IconBoard Member
Card image

Restor3d

Patient-specific 3D-printed implants

Kevin Rocco IconKevin Rocco
Year IconNA
Card image

RevMedica

Innovative semi-reusable laproscopic stapler

Kevin Rocco IconKevin Rocco
Year Icon2022
Card image

TYBR Health

Hydrogel to improve post-operative recovery

Kevin Rocco IconKevin Rocco
Year Icon2025
Card image

Veradermics

Non-hormonal oral therapeutic for hair regrowth

Kevin Rocco IconKevin Rocco
Year IconNA
Star IconExited

Let’s Chat

If your life sciences innovation fits our investment criteria and you're seeking Seed-stage to Series A funding, we'd like to hear from you.